SNEX · StoneX Group Inc.

Current Thesis

StoneX Group's recovery case depends on quarterly revenue stabilizing and the shares regaining the September 4 reference close; fiscal Q4 results and a recovery above $69.46 would test it, while a weekly close below $64 would invalidate it. The latest evidence weakens the recovery case: the adjusted close was $67.00 on 2026-09-18, compared with $69.46 on 2026-09-04, and the 14-day relative strength index (RSI) fell from 53.9 to 43.6 across those observations.

The narrative is dead in its former momentum form — the supplied 2026-09-18 price record shows a three-month decline of 27.6% and a close 27.7% below the 52-week high. A recovery remains a separate, low-conviction hypothesis. Its measurable confirmation would require fiscal Q4 net operating revenue at or above the $719.7 million reported for Q3 on 2026-08-05, together with a weekly close above the September 4 reference level before the $64 invalidation occurs.

The substantive change since the September 6 dossier is the September 9 announcement that City Index UK would become StoneX Trading, with the legacy brand scheduled to retire on September 12. The announcement described unchanged platforms and support services; it supplied no revenue forecast demonstrating that the rebranding would reverse the Self-Directed segment's decline. StoneX announcement, 2026-09-09

Bullish and bearish views on StoneX Group Inc.

The model's bull view on StoneX Group Inc. (SNEX), in brief: Annual growth remains substantial. StoneX's 2026-08-05 fiscal Q3 release reported net operating revenue of $719.7 million, up 47% year over year, and net income of $127.9 million, up 102%. These are measured annual gains; they do not establish sequential stabilization. Fiscal Q3… The bear view: Sequential earnings have already weakened. Both cases follow in full.

Bull Case

• Annual growth remains substantial. StoneX's 2026-08-05 fiscal Q3 release reported net operating revenue of $719.7 million, up 47% year over year, and net income of $127.9 million, up 102%. These are measured annual gains; they do not establish sequential stabilization. Fiscal Q3 results
• Derivatives activity supports the business. The same release reported fiscal Q3 listed-derivatives revenue of $284.3 million, up 125% year over year, and an average rate per contract of $2.61, up 23%. The revenue increase therefore accompanied higher unit revenue, rather than depending exclusively on contract growth. Fiscal Q3 results
• Repurchase authority extends into October. The 2026-08-26 Form 8-K authorized repurchases of up to 5.0 million company shares during fiscal 2027, beginning 2026-10-01. This establishes permission for corporate demand; the authorization itself does not establish purchases.

Bear Case

• Sequential earnings have already weakened. The August 5 results and August 6 call materials recorded fiscal Q3 net operating revenue down 13% from fiscal Q2's $829.1 million, while net income fell 27% from $174.3 million. Another quarter below Q3's $719.7 million revenue would contradict the stabilization case.
• Retail weakness precedes the rebranding. Fiscal Q3 Self-Directed operating revenue fell 13% year over year to $96.3 million, according to the 2026-08-05 release. The September 9 brand announcement contains no financial evidence that this decline has reversed. Fiscal Q3 results
• The rebound has lost ground. The supplied adjusted closes show $69.46 on 2026-09-04 and $67.00 on 2026-09-18. Those observations support a retracement of the rebound; they are too sparse to establish a durable base or renewed accumulation.

Setup & Price Structure

The market's 2026-08-11 adjusted close of $64.85 remains the lower historical reference in the supplied record. The September 18 close of $67.00 remains above it, but below September 4's $69.46. A weekly close above $69.46 would satisfy the price component of the recovery case; a weekly close below $64 would break it. Neither condition has been established by the supplied September 18 close.

The positioning evidence is historical and mixed. SEC Form 4 summaries cited in the August coverage reported Chief Governance and Legal Officer Diego Rotsztain's sale of 20,630 shares on 2026-07-24, director John Moore Fowler's sale of 1,575 shares on 2026-08-05, and director Dhamu R. These third-party transactions do not establish September positioning. Current short interest, fund flows and moving-average measurements are missing, so the evidence does not support a crowding conclusion.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Fiscal year ends. The prior repurchase authorization expires on this date, as described in the 2026-08-26 authorization update. This is an accounting and authorization boundary, without an accompanying earnings release established by the evidence.
• 2026-10-01 — New authorization begins. The August 26 Form 8-K makes the fiscal 2027 repurchase program effective on this date. Subsequent reported repurchases would establish execution; the start date alone cannot demonstrate corporate demand.
• ~2026-11-23, estimated — Fiscal Q4 results. Beyond the next 30 days, MarketBeat estimates this reporting date as of 2026-09-20. StoneX's own events page lists no upcoming event, so the date remains unconfirmed and replaces the earlier dossier's December assumption. The report would test revenue stabilization against fiscal Q3's $719.7 million. MarketBeat earnings calendar, StoneX events calendar

What Would Change Our Mind

Loss of the August price structure would end the recovery case: a weekly close below $64 would put the shares beneath the supplied 2026-08-11 closing reference of $64.85. Independently, fiscal Q4 net operating revenue below the $719.7 million reported on August 5 would refute the specified stabilization condition.

Confirmation requires both a weekly close above the 2026-09-04 reference of $69.46 and fiscal Q4 net operating revenue at or above that Q3 figure before price invalidation. The October 1 authorization date passing without an immediate purchase announcement would not, by itself, disprove the case: the August 26 filing establishes an authorization window, not a commitment to transact on its opening day.

Correlation Notes

This remains a single-name recovery case. The fiscal Q3 disclosures released on 2026-08-05 identify listed derivatives and client activity as concrete operating exposures; average daily client equity was $15.0 billion, up 129% year over year. That identifies a business channel, not a measured relationship between SNEX shares and any index, cryptocurrency or prediction-market theme. No paired return series or current theme-participation evidence accompanies the September 18 price record, so a group-driven recovery claim is unsupported.